US89853L2034 - Common Stock
0.2209 +0.04 (+23.89%)
After market: 0.2123 -0.01 (-3.89%)
T2 BIOSYSTEMS INC
NASDAQ:TTOO (9/29/2023, 7:05:24 PM)After market: 0.2123 -0.01 (-3.89%)
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. The company is headquartered in Lexington, Massachusetts and currently employs 158 full-time employees. The company went IPO on 2014-08-07. The firm is focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. The firm is using its T2MR technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its primary commercial products include the T2Candida Panel and the T2Bacteria Panel. Its T2Candida Panel is a direct-from-blood test that identifies the lethal form of common bloodstream infections that cause sepsis and candidemia. Its T2Bacteria Panel is a direct-from-blood test that detects certain bacterial pathogens associated with sepsis. Its primary commercial products also include the T2Dx Instrument, the T2Resistance Panel, and the T2SARS-CoV-2 Panel.
T2 BIOSYSTEMS INC
101 Hartwell Ave
Lexington MASSACHUSETTS 02421
CEO: John Sperzel
Which stocks are most active on Friday?
The cost to borrow fee for TTOO stock currently tallies in at 37.62%, up significantly compared to the reading of 16.06% on Sept. 18.
These stocks are gapping in today's session
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news traders need to know about on Friday!
These stocks are the most active in today's session
T2 Biosystems faces financial concerns as insiders sell off shares, signaling uncertainty about the company's future prospects.
Here you can normally see the latest stock twits on TTOO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.